Generation Bio Co. Statistics

Total Valuation

GBIO has a market cap or net worth of $144.16 million. The enterprise value is $21.18 million.

Market Cap	144.16M
Enterprise Value	21.18M

Important Dates

The next estimated earnings date is Friday, November 15, 2024, after market close.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

GBIO has 66.74 million shares outstanding. The number of shares has increased by 8.53% in one year.

Shares Outstanding	66.74M
Shares Change (YoY)	+8.53%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	5.75%
Owned by Institutions (%)	71.98%
Float	48.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.86
Forward PS	24.92
PB Ratio	1.25
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.42, with a Debt / Equity ratio of 0.81.

Current Ratio	7.42
Quick Ratio	7.25
Debt / Equity	0.81
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -85.71% and return on invested capital (ROIC) is -25.70%.

Return on Equity (ROE)	-85.71%
Return on Assets (ROA)	-20.87%
Return on Capital (ROIC)	-25.70%
Revenue Per Employee	$75,713
Profits Per Employee	-$910,489
Employee Count	174
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +63.64% in the last 52 weeks. The beta is 2.82, so GBIO's price volatility has been higher than the market average.

Beta (5Y)	2.82
52-Week Price Change	+63.64%
50-Day Moving Average	2.43
200-Day Moving Average	2.76
Relative Strength Index (RSI)	42.58
Average Volume (20 Days)	82,787

Short Selling Information

The latest short interest is 1.74 million, so 2.60% of the outstanding shares have been sold short.

Short Interest	1.74M
Short Previous Month	2.01M
Short % of Shares Out	2.60%
Short % of Float	3.56%
Short Ratio (days to cover)	14.70

Income Statement

In the last 12 months, GBIO had revenue of $13.17 million and -$158.43 million in losses. Loss per share was -$2.39.

Revenue	13.17M
Gross Profit	-53.41M
Operating Income	-111.89M
Pretax Income	-158.43M
Net Income	-158.43M
EBITDA	-106.70M
EBIT	-111.89M
Loss Per Share	-$2.39

Full Income Statement

Balance Sheet

The company has $216.94 million in cash and $93.96 million in debt, giving a net cash position of $122.99 million or $1.84 per share.

Cash & Cash Equivalents	216.94M
Total Debt	93.96M
Net Cash	122.99M
Net Cash Per Share	$1.84
Equity (Book Value)	115.41M
Book Value Per Share	1.73
Working Capital	193.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$103.11 million and capital expenditures -$7.12 million, giving a free cash flow of -$110.23 million.

Operating Cash Flow	-103.11M
Capital Expenditures	-7.12M
Free Cash Flow	-110.23M
FCF Per Share	-$1.65

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-849.35%
Pretax Margin	-1,202.56%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-835.92%

Dividends & Yields

GBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.53%
Shareholder Yield	-8.53%
Earnings Yield	-109.89%
FCF Yield	-76.46%

Analyst Forecast

The average price target for GBIO is $7.50, which is 247.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.50
Price Target Difference	247.22%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	13.14%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GBIO has an Altman Z-Score of -3.18 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.18
Piotroski F-Score	3